Brevan Howard Capital Management LP Acquires 44,280 Shares of Sotera Health (NASDAQ:SHC)

Brevan Howard Capital Management LP increased its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 127.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,156 shares of the company's stock after buying an additional 44,280 shares during the period. Brevan Howard Capital Management LP's holdings in Sotera Health were worth $1,083,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in SHC. Two Seas Capital LP boosted its stake in Sotera Health by 624.0% in the fourth quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after acquiring an additional 2,496,136 shares during the last quarter. Ananym Capital Management LP bought a new position in shares of Sotera Health in the 4th quarter worth $13,680,000. Norges Bank acquired a new stake in shares of Sotera Health during the fourth quarter worth $12,764,000. Walleye Capital LLC increased its holdings in Sotera Health by 818.2% in the fourth quarter. Walleye Capital LLC now owns 775,000 shares of the company's stock valued at $10,602,000 after purchasing an additional 690,597 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Sotera Health by 27.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock worth $43,004,000 after buying an additional 673,979 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Down 1.1%

Shares of SHC stock traded down $0.15 during trading hours on Tuesday, hitting $13.35. 421,465 shares of the company were exchanged, compared to its average volume of 1,192,892. The company has a market capitalization of $3.79 billion, a PE ratio of 53.40 and a beta of 1.88. The business has a 50 day moving average of $11.48 and a two-hundred day moving average of $12.90. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. The company had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company's quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.13 EPS. Analysts anticipate that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SHC. Piper Sandler cut their price target on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Finally, Barclays lowered their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Sotera Health presently has a consensus rating of "Moderate Buy" and an average target price of $15.80.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.